Showing results (631-640 of 1,372) with videos related to

Sort By:
Pageof 138
Current Drug Safety|July 13, 2013
Risk factors for serious adverse effects of thiopurines in patients with Crohn's diseaseYoav Mazor, Eduard Koifman, Hela Elkin, et al.
Archives of Gynecology and Obstetrics|January 1, 1988
Plasma and urine beta-thromboglobulin in severe preeclampsiaJ R Leiberman, Z J Hagay, M Mazor, et al.
Obstetrics and Gynecology|July 1, 1988
The clinical value of gas-liquid chromatography in the detection of intra-amniotic microbial invasionR Romero, K Scharf, M Mazor, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|May 2, 2022
Molecularly Confirmed Female Donor-Transmitted Lobular Breast Cancer to Male following Renal TransplantationJonah M Cooper, Benzion Samueli, Elad Mazor, et al.
The Journal of Reproductive Medicine|October 1, 1989
Is there an association between colonization with group B Streptococcus and prematurity?R Romero, M Mazor, E Oyarzun, et al.
Journal of Autoimmunity|November 19, 2013
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspectsCarlo Perricone, Serena Colafrancesco, Roei D Mazor, et al.
European Journal of Internal Medicine|September 26, 2016
Prospective study of the impact of diabetes mellitus newly diagnosed by glycated hemoglobin on outcomes in patients undergoing percutaneous coronary interventionMuhammad Abu Tailakh, Michael Friger, Doron Zahger, et al.
Frontiers in Health Services|July 7, 2025
Error disclosure: what residents say and what patients find effectiveEmily Grossniklaus, Angelo D'Addario, Ann King, et al.
Molecular Therapy. Methods & Clinical Development|September 10, 2025
AAV2 delivery of the <i>saCas9</i> gene results in presentation of an HLA-A<sup>∗</sup>02:01-restricted T cell epitope potent to induce T cell cytotoxicitySusana S Najera, Annalisa Nicastri, Sojin Bing, et al.
Molecular Therapy. Nucleic Acids|May 29, 2026
FACS-based dual fluorescence reporter assay demonstrates efficacy of antisense oligonucleotide therapy of novel <i>PRPF3</i> intronic splice variantVadim Dolgin, Ekaterina Eremenko, Ginat Narkis, et al.
Pageof 138